Nervive Pain Relieving Cream
NDC Package 84126-318-03
Package Information
Nervive Pain Relieving (lidocaine hcl and menthol) cream is adults and children over 12 years:apply a thin layer to affected area every 6 to 8 hoursdo not exceed 3 applications in a 24 hour periodmassage into painful area until thoroughly absorbed into skinAFTER APPLYING, WASH HANDS WITH SOAP AND WATER children 12 years or younger: ask a doctor. This formulation utilizes a cream delivery system. Marketed by The Procter & Gamble Manufacturing Company, this product is identified by NDC 84126-318 and is authorized under FDA application M017.
Identification & Billing
- RxCUI: 1595624 - lidocaine HCl 4 % / menthol 1 % Topical Cream
- RxCUI: 1595624 - lidocaine hydrochloride 40 MG/ML / menthol 10 MG/ML Topical Cream
- RxCUI: 1595624 - lidocaine hydrochloride 4 % / menthol 1 % Topical Cream
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 84126 - The Procter & Gamble Manufacturing Company
- 84126-318 - Nervive Pain Relieving
- 84126-318-03 - 1 TUBE in 1 CARTON / 85.1 g in 1 TUBE
- 84126-318 - Nervive Pain Relieving
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 84126-318-03 identifies a specific commercial package of 1 tube in 1 carton / 85.1 g in 1 tube of Nervive Pain Relieving Cream, a human over the counter drug labeled by The Procter & Gamble Manufacturing Company. This cream is formulated for topical use and contains lidocaine hydrochloride anhydrous; menthol as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by The Procter & Gamble Manufacturing Company on August 12, 2024. The current certification is valid through December 31, 2027.
How is this The Procter & Gamble Manufacturing Company product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 84126031803. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.